Liberating Technologies, Inc.
15
3
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
13.3%
2 terminated/withdrawn out of 15 trials
81.8%
-4.7% vs industry average
0%
0 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Wireless Prosthetic Control Effectiveness Study
Role: lead
Caesar Foot Take-Home Validation Testing
Role: lead
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
Role: lead
Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees
Role: lead
Clinical Outcomes With Passive MPKs vs. Powered Prosthetic Knees
Role: lead
Moisture Management Liner At-Home Evaluation
Role: lead
Moisture Management Liner Effectiveness Study
Role: lead
Dexterous Partial Hand Prosthesis Outcomes
Role: lead
Evaluation of Dexterous Terminal Device
Role: lead
Socket Cooling Effectiveness Take Home Study
Role: lead
Myoelectric Game Training and Outcomes
Role: lead
EMG-Based Hand-Wrist Control: Study B Mirrored
Role: lead
Functional Outcomes of Voice Recognition Prosthesis
Role: lead
Hand Assistive Rehabilitation Orthotic Device Effectiveness Study
Role: lead
Evaluation of a Pro-Active Dynamic Accommodating Socket
Role: collaborator
All 15 trials loaded